InveniAI® and Kyowa Kirin have expanded their longstanding relationship with a new, multiple drug discovery agreement.
The collaboration will provide Kyowa Kirin with access to InveniAI’s AI Innovation Lab and AI Technology Platform, AlphaMeld®, to expand the scope of Kyowa Kirin’s drug discovery programs.